Biobytes

The World's First Multicenter Biobank Dedicated to Sarcopenia

What Is a Biobank?

M-Bank is the world's first multicenter biobank of older adults dedicated to patients with sarcopenia. Led by Wonju Severance Christian Hospital together with Kangbuk Samsung Hospital, it collects blood, muscle tissue, physical function, and clinical and genomic data in one integrated cohort, with 830 participants enrolled as of November 2026 toward a target of 3,000 by 2027. The accumulated data drives the advancement of MyoTest and the discovery of drug biomarkers, and Biobytes holds exclusive rights to use all data and outputs for 15 years.

Multicenter Collaboration Across Wonju Severance and Kangbuk Samsung Hospitals

  • Multicenter Collaboration

  • Comprehensive Data

  • Practical Applications

  • E-CRF System

  • Sarco-Finding

Core Biobank Capabilities

Data Collection Status

  • Total Participants830
  • Partner Institutions2
  • Related Patents4
  • Publications10
Monthly Participant Growth2025.03 - 2026.11
  • Total
79 people830 people
  1. 2025.03
  2. 2025.07
  3. 2025.11
  4. 2026.03
  5. 2026.07
  6. 2026.11
Monthly Sarcopenia Trends2025.03 - 2026.11
  • Proportion (%)
  • Participants with sarcopenia
11.4%20.6%
  1. 2025.03
  2. 2025.07
  3. 2025.11
  4. 2026.03
  5. 2026.07
  6. 2026.11
Participants by Age Group2025.03 - 2026.11
311 people346 people
  1. 20-29
  2. 30-39
  3. 40-49
  4. 50-59
  5. 60-69
  6. 70-79
  7. 80+
Gender Distribution2025.03 - 2026.11
63%37%
FemaleMale63 : 37

Explore Live Biobank Data

Experience the new paradigm of drug development firsthand

View Live Data